\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\:\ \(1\)\
\-\ vitals\\ wnl\ \(0\)\
\-\ cardio\\,\\ pulm\\,\\ abdominal\\ exam\\ were\\ all\\ unremarkable\\.\ \(0\)\
\-\ l\\ fifth\\ digit\\ swollen\\.\\ non\\ tender\\ to\\ palpation\\,\\ but\\ range\\ of\\ motion\\ limited\\ secondary\\ to\\ swollen\\ size\\.\\ non\\ erythematous\\.\\ no\\ overlying\\ skin\\ changes\\.\\ sensation\\ intact\\.\\ radial\\ pulse\\ palpable\\.\ \(0\)\
\-\ enchondromas\\ are\\ treated\\ expectantly\\,\\ and\\ may\\ be\\ followed\\ serially\\ to\\ rule\\ out\\ aggressive\\ transformation\\ \\(2\\,3\\,7\\)\\.\\ pathologic\\ fractures\\ are\\ often\\ treated\\ non\\-operatively\\,\\ with\\ immobilization\\ \\(2\\,3\\)\\.\\ surgical\\ management\\ may\\ be\\ explored\\ if\\ there\\ is\\ concern\\ for\\ future\\ fractures\\,\\ symptomatic\\ findings\\,\\ and\\/or\\ fear\\ of\\ malignancy\\.\\ curettage\\ with\\ or\\ without\\ bone\\ grafting\\,\\ followed\\ by\\ immobilization\\,\\ physical\\ therapy\\,\\ and\\ serial\\ radiographs\\ \\(at\\ the\\ 3\\,5\\,\\ and\\ 12\\ month\\ mark\\ in\\ both\\ operative\\ and\\ non\\-operative\\ patients\\)\\ may\\ be\\ done\\ in\\ these\\ settings\\ \\(2\\,3\\,7\\)\\.\\ therapies\\ like\\ high\\ speed\\ burring\\ or\\ alcohol\\ instillation\\ are\\ not\\ recommended\\ \\(7\\)\\.\ \(0\)\
\-\ fracture\\ through\\ the\\ 5th\\ proximal\\ phalanx\\.\\ \\ underlying\\ lytic\\ lesion\\ with\\ bone\\ expansion\\ and\\ endosteal\\ scalloping\ \(0\)\
\-\ enchondroma\ \(73\)\
\-\ enchondroma\ \(73\)\
\-\ bone\\ infarct\\ \\(but\\ no\\ pain\\/\\ known\\ mechanism\\ or\\ risk\\ factor\\)\ \(0\)\
\-\ chondrosarcoma\\ \\(no\\ pain\\,\\ swelling\\;\\ no\\ aggressive\\ growth\\)\ \(0\)\
\-\ infection\\ \\(no\\ systemic\\ symptoms\\ or\\ mechanism\\ for\\ infection\\)\ \(0\)\
\-\ hpi\\:\\ \ \(0\)\
\-\ a\\ 26yo\\ active\\ duty\\ man\\ presents\\ to\\ his\\ battalion\\ medical\\ officer\\ following\\ an\\ injury\\ during\\ combatives\\ training\\.\\ he\\ states\\ that\\ his\\ finger\\ was\\ caught\\ between\\ his\\ opponent\\?s\\ helmet\\ and\\ the\\ ground\\.\\ it\\ was\\ initially\\ painful\\ and\\ swollen\\,\\ but\\ the\\ pain\\ has\\ since\\ subsided\\.\\ he\\ has\\ no\\ previous\\ injuries\\ to\\ his\\ finger\\ and\\ other\\ symptoms\\.\\ \\ \ \(0\)\
\-\ to\\ rule\\ out\\ a\\ fracture\\,\\ a\\ hand\\ x\\-ray\\ was\\ obtained\\.\\ the\\ following\\ image\\ was\\ noted\\.\ \(0\)\
\-\ he\\ presents\\ to\\ your\\ clinic\\ for\\ work\\ up\\ of\\ hand\\ finding\\.\ \(0\)\
\-\ pmh\\:\\ unremarkable\ \(0\)\
\-\ psh\\:\\ r\\ inguinal\\ hernia\\ repair\ \(0\)\
\-\ meds\\:\\ multi\\-vitamins\\;\\ pre\\-workout\ \(0\)\
\-\ fam\\ history\\:\\ breast\\ cancer\\ in\\ mother\\;\\ prostate\\ cancer\\ in\\ grand\\ father\ \(0\)\
\-\ these\\ benign\\,\\ osteolytic\\ tumors\\ appear\\ as\\ \\"well\\ defined\\ areas\\ of\\ central\\ lucency\\ in\\ the\\ metaphyseal\\ or\\ diaphyseal\\ portion\\ of\\ the\\ bone\\ \\(1\\)\\.\\"\\ other\\ findings\\ associated\\ with\\ enchondromas\\ include\\ endosteal\\ scalloping\\,\\ thinning\\,\\ stippling\\,\\ and\\ punctate\\ calcifications\\ \\(2\\,3\\)\\.\\ of\\ note\\,\\ larger\\ lesions\\-specifically\\ those\\ in\\ the\\ hand\\-\\ tend\\ to\\ occur\\ further\\ away\\ from\\ the\\ growth\\ plate\\ possibly\\ due\\ to\\ \\?earlier\\ development\\ and\\ migration\\(2\\)\\.\\?\ \(0\)\
\-\ enchondromas\\ are\\ benign\\ intramedullary\\ bone\\ tumors\\ that\\ are\\ believed\\ to\\ arise\\ from\\ cartilaginous\\ fragments\\ near\\ the\\ central\\ physis\\ \\(3\\)\\.\\ other\\ theories\\ with\\ respect\\ to\\ their\\ development\\ include\\ jaffe\\?s\\ hypothesis\\ which\\ postulates\\ that\\ embryonic\\ cartilaginous\\ cells\\ from\\ the\\ epiphyseal\\ plate\\ are\\ displaced\\ during\\ normal\\ growth\\,\\ continue\\ to\\ develop\\,\\ and\\ become\\ enchondromas\\ in\\ the\\ area\\ in\\ which\\ they\\ settle\\ \\(1\\)\\.\\ molecular\\ studies\\ have\\ shown\\ that\\ there\\ is\\ some\\ association\\ with\\ the\\ genes\\ idh1\\ and\\ idh2\\ \\(1\\,\\ 4\\)\\.\\ \ \(0\)\
\-\ epidemiologically\\,\\ enchondromas\\ are\\ the\\ second\\ most\\ common\\ benign\\ bone\\ tumor\\ found\\ in\\ children\\/adolescents\\ \\(with\\ osteochondromas\\ leading\\ the\\ way\\)\\,\\ accounting\\ for\\ up\\ to\\ 24\\%\\ of\\ such\\ tumors\\ \\(1\\)\\.\\ they\\ occur\\ equally\\ in\\ men\\ and\\ women\\;\\ and\\ account\\ for\\ 12\\%\\-14\\%\\ of\\ benign\\ bone\\ tumors\\ and\\ 3\\%\\-10\\%\\ of\\ all\\ bone\\ tumors\\ in\\ the\\ general\\ population\\ \\(3\\)\\.\\ studies\\ have\\ shown\\ that\\ 35\\%\\ of\\ enchondromas\\ arise\\ in\\ the\\ hand\\,\\ with\\ 50\\%\\ of\\ these\\ arising\\ in\\ the\\ proximal\\ phalanx\\ \\(as\\ in\\ our\\ patient\\)\\.\\ enchondromas\\ typically\\ arise\\ in\\ the\\ hands\\ and\\ feet\\,\\ but\\ have\\ also\\ been\\ reported\\ in\\ the\\ femur\\,\\ tibiam\\,\\ calcaneus\\,\\ and\\ atlas\\ \\(1\\,4\\,5\\)\\.\ \(0\)\
\-\ clinical\\ presentation\\ and\\ malignant\\ transformation\\:\ \(0\)\
\-\ these\\ benign\\ tumors\\ are\\ usually\\ asymptomatic\\ and\\ found\\ incidentally\\ on\\ radiographic\\ examination\\ \\(1\\,2\\,3\\,5\\)\\.\\ on\\ occasion\\,\\ the\\ bone\\ loss\\ can\\ lead\\ to\\ pathologic\\ fractures\\ \\(2\\)\\.\\ pain\\ and\\ aggressive\\ progression\\ are\\ atypical\\ and\\ warrants\\ close\\ monitoring\\/\\ further\\ work\\ up\\.\\ though\\ malignant\\ transformation\\ of\\ solitary\\ enchondromas\\ is\\ exceedingly\\ rare\\ \\(1\\)\\,\\ two\\ syndromes\\ should\\ that\\ should\\ be\\ kept\\ in\\ mind\\ are\\ ollier\\ disease\\ \\(multiple\\ enchondromas\\ in\\ several\\ bones\\)\\ and\\ maffucci\\ syndrome\\ \\(multiple\\ enchondromas\\ and\\ hemangiomas\\)\\ \\(6\\)\\.\\ these\\ two\\ diseases\\/syndromes\\ have\\ been\\ associated\\ with\\ higher\\ malignant\\ transformation\\ rates\\ to\\ chondrosarcoma\\,\\ and\\ in\\ maffucci\\ syndrome\\,\\ non\\-skeletal\\ tumors\\ like\\ astrocytomas\\ and\\ granulosa\\-cell\\ ovarian\\ tumor\\ \\(6\\)\\.\ \(0\)\
\-\ histologic\\ findings\\:\ \(0\)\
\-\ enchondromas\\ can\\ be\\ confirmed\\ via\\ histology\\.\\ they\\ are\\ associated\\ with\\ lobulated\\ cartilaginous\\ tissue\\ with\\ \\?banal\\-appearing\\ chondrocytes\\ arranged\\ in\\ clustered\\ lacunae\\ with\\ a\\ background\\ of\\ abundant\\ hyaline\\ cartilage\\ matrix\\ \\(1\\)\\.\\?\\ chondrocytes\\ nuclei\\ are\\ of\\ different\\ sizes\\ and\\ may\\ be\\ binucleate\\.\\ these\\ may\\ be\\ hypo\\-\\ or\\ hypercellular\\,\\ but\\ are\\ not\\ associated\\ with\\ mitoses\\.\\ \ \(0\)\
\-\ resources\\:\ \(0\)\
\-\ 1\\)\\	bierry\\ et\\ al\\.\\ \\?enchondromas\\ in\\ children\\:\\ imaging\\ appearance\\ with\\ pathological\\ correlation\\.\\?\\ skeletal\\ radiology\\.\\ vol\\ 41\\.\\ 1223\\-1229\\.\\ 2010\ \(0\)\
\-\ 2\\)\\	jacobson\\,\\ m\\.\\ and\\ ruff\\,\\ m\\.\\ \\?solitary\\ enchondroma\\ of\\ the\\ phalanx\\.\\?\\ journal\\ of\\ hand\\ surgery\\.\\ vol\\ 36\\.\\ 1845\\-1847\\.\\ 2011\ \(0\)\
\-\ 3\\)\\	reisler\\ et\\ al\\.\\ \\?osseous\\ tumor\\ of\\ the\\ hand\\:\\ finger\\ enchondroma\\.\\?\\ eplasty\\-\\ interesting\\ case\\ series\\.\\ vol\\ \\ 15\\.\\ \\ 2015\\.\ \(0\)\
\-\ 4\\)\\	wani\\ et\\ al\\.\\ \\?isolated\\ enchondroma\\ of\\ atlas\\.\\?\\ turkish\\ neurosurgery\\.\\ vol\\ 21\\ issue\\ 2\\.\\ 2011\ \(0\)\
\-\ 5\\)\\	\\ komurcu\\ et\\ al\\.\\ \\?atypical\\ localization\\ of\\ enchondroma\\ in\\ the\\ calcaneus\\.\\?\\ journal\\ of\\ the\\ american\\ podiatric\\ medical\\ association\\.\\ vol\\ 105\\ issue\\ 3\\.\\ 2015\ \(0\)\
\-\ 6\\)\\	schwartz\\ et\\ al\\.\\ \\?the\\ malignant\\ potential\\ of\\ enchoromatosis\\.\\?\\ the\\ journal\\ of\\ bone\\ and\\ joint\\ surgery\\.\\ vol\\ 69\\ issue\\ 2\\.\\ 1987\\.\ \(0\)\
\-\ 7\\)\\	tang\\ et\\ al\\.\\ \\?current\\ management\\ of\\ hand\\ enchondroma\\:\\ a\\ review\\.\\?\\ hand\\ surgery\\.\\ vol\\ 20\\.\\ 2015\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ enchondromas\\:\\ 0\\.4130143836272907\ \(0\)\
\-\ vol\\:\\ 0\\.22425923667976\ \(0\)\
\-\ enchondroma\\:\\ 0\\.20248196417642247\ \(0\)\
\-\ hand\\:\\ 0\\.17108026719433575\ \(0\)\
\-\ and\\:\\ 0\\.16393795430487676\ \(0\)\
\-\ in\\:\\ 0\\.14972290229359211\ \(0\)\
\-\ bone\\:\\ 0\\.14926947484792844\ \(0\)\
\-\ the\\:\\ 0\\.14738638647385124\ \(0\)\
\-\ tumors\\:\\ 0\\.14083874725262924\ \(0\)\
\-\ are\\:\\ 0\\.13495063035184948\ \(0\)\
\-\ al\\:\\ 0\\.1304217857479756\ \(0\)\
\-\ et\\:\\ 0\\.12858295158797522\ \(0\)\
\-\ of\\:\\ 0\\.12313476146389321\ \(0\)\
\-\ transformation\\:\\ 0\\.11177533522251785\ \(0\)\
\-\ to\\:\\ 0\\.1025887385771665\ \(0\)\
\-\ issue\\:\\ 0\\.09812192884934957\ \(0\)\
\-\ benign\\:\\ 0\\.0939627906726965\ \(0\)\
\-\ cartilaginous\\:\\ 0\\.09277605161657808\ \(0\)\
\-\ these\\:\\ 0\\.09269167940651539\ \(0\)\
\-\ 2015\\:\\ 0\\.09228829244288854\ \(0\)\
\-\ journal\\:\\ 0\\.08330826129385457\ \(0\)\
\-\ phalanx\\:\\ 0\\.0825574378481212\ \(0\)\
\-\ chondrocytes\\:\\ 0\\.08085183016615971\ \(0\)\
\-\ swollen\\:\\ 0\\.07929826729166249\ \(0\)\
\-\ malignant\\:\\ 0\\.07800478226673585\ \(0\)\
\-\ finger\\:\\ 0\\.07799786501042737\ \(0\)\
\-\ be\\:\\ 0\\.07768409031666035\ \(0\)\
\-\ maffucci\\:\\ 0\\.07696273922851903\ \(0\)\
\-\ atlas\\:\\ 0\\.07548417547553782\ \(0\)\
\-\ arise\\:\\ 0\\.07511071183411615\ \(0\)\
\-\ with\\:\\ 0\\.0749963774940596\ \(0\)\
\-\ that\\:\\ 0\\.07123202417257667\ \(0\)\
\-\ aggressive\\:\\ 0\\.07097168093409312\ \(0\)\
\-\ may\\:\\ 0\\.06883505830193722\ \(0\)\
\-\ growth\\:\\ 0\\.06767426524118347\ \(0\)\
\-\ but\\:\\ 0\\.06764092018253666\ \(0\)\
\-\ or\\:\\ 0\\.066619608221845\ \(0\)\
\-\ his\\:\\ 0\\.06636595812988429\ \(0\)\
\-\ non\\:\\ 0\\.06490220464275491\ \(0\)\
\-\ endosteal\\:\\ 0\\.06185070107771872\ \(0\)\
\-\ calcaneus\\:\\ 0\\.06185070107771872\ \(0\)\
\-\ fractures\\:\\ 0\\.060675685016998396\ \(0\)\
\-\ scalloping\\:\\ 0\\.05951395639876436\ \(0\)\
\-\ 2011\\:\\ 0\\.05900901463502791\ \(0\)\
\-\ they\\:\\ 0\\.05864170793043747\ \(0\)\
\-\ associated\\:\\ 0\\.05767720873041617\ \(0\)\
\-\ syndromes\\:\\ 0\\.05624966070167923\ \(0\)\
\-\ have\\:\\ 0\\.05466571173064787\ \(0\)\
\-\ immobilization\\:\\ 0\\.053398519671288454\ \(0\)\
\-\ no\\:\\ 0\\.0533775241276801\ \(0\)\
\-\ mechanism\\:\\ 0\\.05153623761260801\ \(0\)\
\-\ chondrosarcoma\\:\\ 0\\.05017118617194782\ \(0\)\
\-\ plate\\:\\ 0\\.05017118617194782\ \(0\)\
\-\ solitary\\:\\ 0\\.05007380788941076\ \(0\)\
\-\ skeletal\\:\\ 0\\.04960121583068986\ \(0\)\
\-\ association\\:\\ 0\\.04923922274026956\ \(0\)\
\-\ he\\:\\ 0\\.0485998142626477\ \(0\)\
\-\ operative\\:\\ 0\\.0458983769286079\ \(0\)\
\-\ development\\:\\ 0\\.045232441019997814\ \(0\)\
\-\ atypical\\:\\ 0\\.044887792741618644\ \(0\)\
\-\ pathologic\\:\\ 0\\.044831536401789725\ \(0\)\
\-\ children\\:\\ 0\\.044831536401789725\ \(0\)\
\-\ work\\:\\ 0\\.044609753609017824\ \(0\)\
\-\ surgery\\:\\ 0\\.0441251826389616\ \(0\)\
\-\ burring\\:\\ 0\\.04375013751857454\ \(0\)\
\-\ 26yo\\:\\ 0\\.04375013751857454\ \(0\)\
\-\ combatives\\:\\ 0\\.04375013751857454\ \(0\)\
\-\ stippling\\:\\ 0\\.04375013751857454\ \(0\)\
\-\ jaffe\\:\\ 0\\.04375013751857454\ \(0\)\
\-\ postulates\\:\\ 0\\.04375013751857454\ \(0\)\
\-\ idh2\\:\\ 0\\.04375013751857454\ \(0\)\
\-\ epidemiologically\\:\\ 0\\.04375013751857454\ \(0\)\
\-\ tibiam\\:\\ 0\\.04375013751857454\ \(0\)\
\-\ bierry\\:\\ 0\\.04375013751857454\ \(0\)\
\-\ ruff\\:\\ 0\\.04375013751857454\ \(0\)\
\-\ reisler\\:\\ 0\\.04375013751857454\ \(0\)\
\-\ wani\\:\\ 0\\.04375013751857454\ \(0\)\
\-\ komurcu\\:\\ 0\\.04375013751857454\ \(0\)\
\-\ enchoromatosis\\:\\ 0\\.04375013751857454\ \(0\)\
\-\ rule\\:\\ 0\\.0434253630184214\ \(0\)\
\-\ tumor\\:\\ 0\\.04292822723408907\ \(0\)\
\-\ other\\:\\ 0\\.04262111807833101\ \(0\)\
\-\ shown\\:\\ 0\\.04241477883143214\ \(0\)\
\-\ expectantly\\:\\ 0\\.041805592049754196\ \(0\)\
\-\ grand\\:\\ 0\\.041805592049754196\ \(0\)\
\-\ binucleate\\:\\ 0\\.041805592049754196\ \(0\)\
\-\ podiatric\\:\\ 0\\.041805592049754196\ \(0\)\
\-\ tang\\:\\ 0\\.041805592049754196\ \(0\)\
\-\ for\\:\\ 0\\.041458804852910154\ \(0\)\
\-\ like\\:\\ 0\\.04066600908507271\ \(0\)\
\-\ up\\:\\ 0\\.04059774561587295\ \(0\)\
\-\ findings\\:\\ 0\\.04050564413658848\ \(0\)\
\-\ serially\\:\\ 0\\.040425915083079855\ \(0\)\
\-\ battalion\\:\\ 0\\.040425915083079855\ \(0\)\
\-\ opponent\\:\\ 0\\.040425915083079855\ \(0\)\
\-\ settle\\:\\ 0\\.040425915083079855\ \(0\)\
\-\ idh1\\:\\ 0\\.040425915083079855\ \(0\)\
\-\ hypercellular\\:\\ 0\\.040425915083079855\ \(0\)\
\-\ schwartz\\:\\ 0\\.040425915083079855\ \(0\)\
\-\ management\\:\\ 0\\.04041499756757767\ \(0\)\
\-\ occur\\:\\ 0\\.04023964207217979\ \(0\)\
\-\ studies\\:\\ 0\\.04013594724121228\ \(0\)\
\-\ helmet\\:\\ 0\\.03935575448743923\ \(0\)\
\-\ lacunae\\:\\ 0\\.03935575448743923\ \(0\)\
\-\ jacobson\\:\\ 0\\.03935575448743923\ \(0\)\
\-\ pain\\:\\ 0\\.03915766880384562\ \(0\)\
\-\ fear\\:\\ 0\\.03848136961425951\ \(0\)\
\-\ instillation\\:\\ 0\\.03848136961425951\ \(0\)\
\-\ turkish\\:\\ 0\\.03848136961425951\ \(0\)\
\-\ was\\:\\ 0\\.03813703679205174\ \(0\)\
\-\ subsided\\:\\ 0\\.03774208773776891\ \(0\)\
\-\ warrants\\:\\ 0\\.03774208773776891\ \(0\)\
\-\ exceedingly\\:\\ 0\\.03774208773776891\ \(0\)\
\-\ 12\\:\\ 0\\.03740241210796203\ \(0\)\
\-\ explored\\:\\ 0\\.03710169264758517\ \(0\)\
\-\ theories\\:\\ 0\\.03710169264758517\ \(0\)\
\-\ genes\\:\\ 0\\.03710169264758517\ \(0\)\
\-\ mitoses\\:\\ 0\\.03710169264758517\ \(0\)\
\-\ resources\\:\\ 0\\.03710169264758517\ \(0\)\
\-\ followed\\:\\ 0\\.03694798446290601\ \(0\)\
\-\ unremarkable\\:\\ 0\\.03668051855766099\ \(0\)\
\-\ central\\:\\ 0\\.03653771177412873\ \(0\)\
\-\ mark\\:\\ 0\\.03653682414543917\ \(0\)\
\-\ officer\\:\\ 0\\.03653682414543917\ \(0\)\
\-\ fam\\:\\ 0\\.03653682414543917\ \(0\)\
\-\ clustered\\:\\ 0\\.03653682414543917\ \(0\)\
\-\ cancer\\:\\ 0\\.036443674957727185\ \(0\)\
\-\ caught\\:\\ 0\\.036031532051944544\ \(0\)\
\-\ out\\:\\ 0\\.03596456169525007\ \(0\)\
\-\ should\\:\\ 0\\.03570115809169277\ \(0\)\
\-\ further\\:\\ 0\\.035636422108422466\ \(0\)\
\-\ cardio\\:\\ 0\\.035574439753335435\ \(0\)\
\-\ hpi\\:\\ 0\\.035574439753335435\ \(0\)\
\-\ hypothesis\\:\\ 0\\.035574439753335435\ \(0\)\
\-\ embryonic\\:\\ 0\\.035574439753335435\ \(0\)\
\-\ occasion\\:\\ 0\\.035574439753335435\ \(0\)\
\-\ abundant\\:\\ 0\\.035574439753335435\ \(0\)\
\-\ 1987\\:\\ 0\\.035574439753335435\ \(0\)\
\-\ found\\:\\ 0\\.03540272624524885\ \(0\)\
\-\ settings\\:\\ 0\\.034773275221828985\ \(0\)\
\-\ medical\\:\\ 0\\.03477320506206524\ \(0\)\
\-\ during\\:\\ 0\\.03465599368357998\ \(0\)\
\-\ molecular\\:\\ 0\\.034417865302274225\ \(0\)\
\-\ ollier\\:\\ 0\\.034417865302274225\ \(0\)\
\-\ proximal\\:\\ 0\\.03418246819176425\ \(0\)\
\-\ osteochondromas\\:\\ 0\\.0340869865831242\ \(0\)\
\-\ treated\\:\\ 0\\.03407221780038777\ \(0\)\
\-\ mind\\:\\ 0\\.03377747021209049\ \(0\)\
\-\ hyaline\\:\\ 0\\.03377747021209049\ \(0\)\
\-\ arranged\\:\\ 0\\.033486724272934004\ \(0\)\
\-\ kept\\:\\ 0\\.033212601709944486\ \(0\)\
\-\ infection\\:\\ 0\\.03305067795436048\ \(0\)\
\-\ syndrome\\:\\ 0\\.032985205492328404\ \(0\)\
\-\ following\\:\\ 0\\.03282345328731873\ \(0\)\
\-\ diaphyseal\\:\\ 0\\.03270730961644986\ \(0\)\
\-\ astrocytomas\\:\\ 0\\.03270730961644986\ \(0\)\
\-\ from\\:\\ 0\\.03259537423013897\ \(0\)\
\-\ all\\:\\ 0\\.032570192938820026\ \(0\)\
\-\ include\\:\\ 0\\.0325545840200865\ \(0\)\
\-\ two\\:\\ 0\\.03249240112193861\ \(0\)\
\-\ accounting\\:\\ 0\\.03247331983345388\ \(0\)\
\-\ therapies\\:\\ 0\\.03203703381139429\ \(0\)\
\-\ speed\\:\\ 0\\.03203703381139429\ \(0\)\
\-\ your\\:\\ 0\\.03203703381139429\ \(0\)\
\-\ psh\\:\\ 0\\.03203703381139429\ \(0\)\
\-\ osteolytic\\:\\ 0\\.03203703381139429\ \(0\)\
\-\ been\\:\\ 0\\.031877243022802086\ \(0\)\
\-\ equally\\:\\ 0\\.031832924743270145\ \(0\)\
\-\ grafting\\:\\ 0\\.031637149020809226\ \(0\)\
\-\ sizes\\:\\ 0\\.0314490527863343\ \(0\)\
\-\ pulm\\:\\ 0\\.03126805624112415\ \(0\)\
\-\ localization\\:\\ 0\\.03126805624112415\ \(0\)\
\-\ fracture\\:\\ 0\\.031096093546377865\ \(0\)\
\-\ training\\:\\ 0\\.030762764147629518\ \(0\)\
\-\ respect\\:\\ 0\\.030762764147629518\ \(0\)\
\-\ background\\:\\ 0\\.030762764147629518\ \(0\)\
\-\ histologic\\:\\ 0\\.030605509429236195\ \(0\)\
\-\ 105\\:\\ 0\\.030453247776595808\ \(0\)\
\-\ epiphyseal\\:\\ 0\\.03030567184902041\ \(0\)\
\-\ curettage\\:\\ 0\\.03016250183743932\ \(0\)\
\-\ nuclei\\:\\ 0\\.03016250183743932\ \(0\)\
\-\ digit\\:\\ 0\\.03002348227113891\ \(0\)\
\-\ intramedullary\\:\\ 0\\.03002348227113891\ \(0\)\
\-\ symptoms\\:\\ 0\\.02993663331270667\ \(0\)\
\-\ meds\\:\\ 0\\.02988837927444981\ \(0\)\
\-\ hemangiomas\\:\\ 0\\.02988837927444981\ \(0\)\
\-\ physical\\:\\ 0\\.029667416611108516\ \(0\)\
\-\ physis\\:\\ 0\\.029383087180955177\ \(0\)\
\-\ believed\\:\\ 0\\.029264665380988274\ \(0\)\
\-\ father\\:\\ 0\\.0291490973979592\ \(0\)\
\-\ 2010\\:\\ 0\\.0291490973979592\ \(0\)\
\-\ thinning\\:\\ 0\\.029036248915554456\ \(0\)\
\-\ histology\\:\\ 0\\.029036248915554456\ \(0\)\
\-\ migration\\:\\ 0\\.028925994882346068\ \(0\)\
\-\ interesting\\:\\ 0\\.028925994882346068\ \(0\)\
\-\ metaphyseal\\:\\ 0\\.028712811375899604\ \(0\)\
\-\ 69\\:\\ 0\\.028712811375899604\ \(0\)\
\-\ can\\:\\ 0\\.028712396248988487\ \(0\)\
\-\ way\\:\\ 0\\.02860967107337377\ \(0\)\
\-\ punctate\\:\\ 0\\.028508702307775465\ \(0\)\
\-\ rates\\:\\ 0\\.028508702307775465\ \(0\)\
\-\ pathological\\:\\ 0\\.028508702307775465\ \(0\)\
\-\ away\\:\\ 0\\.028409815521468592\ \(0\)\
\-\ tend\\:\\ 0\\.027943833805629464\ \(0\)\
\-\ men\\:\\ 0\\.027855834286705437\ \(0\)\
\-\ account\\:\\ 0\\.027855834286705437\ \(0\)\
\-\ erythematous\\:\\ 0\\.027769420431284858\ \(0\)\
\-\ neurosurgery\\:\\ 0\\.02768453610520989\ \(0\)\
\-\ inguinal\\:\\ 0\\.027601128103364677\ \(0\)\
\-\ exam\\:\\ 0\\.0275432683127629\ \(0\)\
\-\ matrix\\:\\ 0\\.027519145949373734\ \(0\)\
\-\ future\\:\\ 0\\.027438541712134834\ \(0\)\
\-\ correlation\\:\\ 0\\.02728128699374151\ \(0\)\
\-\ fifth\\:\\ 0\\.027204551929138857\ \(0\)\
\-\ continue\\:\\ 0\\.026838279401944637\ \(0\)\
\-\ multiple\\:\\ 0\\.02676201549109836\ \(0\)\
\-\ ground\\:\\ 0\\.026631232606792957\ \(0\)\
\-\ prostate\\:\\ 0\\.026498006283664288\ \(0\)\
\-\ presents\\:\\ 0\\.026320462098394396\ \(0\)\
\-\ fragments\\:\\ 0\\.026180284882019275\ \(0\)\
\-\ isolated\\:\\ 0\\.02599928833680912\ \(0\)\
\-\ duty\\:\\ 0\\.02594044294549359\ \(0\)\
\-\ hands\\:\\ 0\\.02594044294549359\ \(0\)\
\-\ cartilage\\:\\ 0\\.02594044294549359\ \(0\)\
\-\ population\\:\\ 0\\.02588231084922251\ \(0\)\
\-\ pulse\\:\\ 0\\.025824874962464515\ \(0\)\
\-\ possibly\\:\\ 0\\.025712026480059772\ \(0\)\
\-\ feet\\:\\ 0\\.025712026480059772\ \(0\)\
\-\ wnl\\:\\ 0\\.025656582634544338\ \(0\)\
\-\ factor\\:\\ 0\\.025656582634544338\ \(0\)\
\-\ 5th\\:\\ 0\\.025441003005528668\ \(0\)\
\-\ alcohol\\:\\ 0\\.025285448637879085\ \(0\)\
\-\ lobulated\\:\\ 0\\.025234698542894913\ \(0\)\
\-\ serial\\:\\ 0\\.025184479872280785\ \(0\)\
\-\ develop\\:\\ 0\\.025184479872280785\ \(0\)\
\-\ concern\\:\\ 0\\.02508559308597391\ \(0\)\
\-\ progression\\:\\ 0\\.02508559308597391\ \(0\)\
\-\ 41\\:\\ 0\\.02508559308597391\ \(0\)\
\-\ series\\:\\ 0\\.02508559308597391\ \(0\)\
\-\ different\\:\\ 0\\.02503690394470538\ \(0\)\
\-\ has\\:\\ 0\\.024991954551878914\ \(0\)\
\-\ earlier\\:\\ 0\\.024988704149819862\ \(0\)\
\-\ expansion\\:\\ 0\\.024940983962837386\ \(0\)\
\-\ which\\:\\ 0\\.024879192889390275\ \(0\)\
\-\ higher\\:\\ 0\\.02484694488665974\ \(0\)\
\-\ pmh\\:\\ 0\\.024754714366823884\ \(0\)\
\-\ close\\:\\ 0\\.024754714366823884\ \(0\)\
\-\ women\\:\\ 0\\.02461961137013478\ \(0\)\
\-\ larger\\:\\ 0\\.024488210295067155\ \(0\)\
\-\ potential\\:\\ 0\\.024445197995790174\ \(0\)\
\-\ lead\\:\\ 0\\.024360313669715205\ \(0\)\
\-\ leading\\:\\ 0\\.02431842834476429\ \(0\)\
\-\ systemic\\:\\ 0\\.024276905667869993\ \(0\)\
\-\ become\\:\\ 0\\.024276905667869993\ \(0\)\
\-\ our\\:\\ 0\\.024235739413198933\ \(0\)\
\-\ painful\\:\\ 0\\.02419492351387905\ \(0\)\
\-\ vitals\\:\\ 0\\.024154452056633687\ \(0\)\
\-\ states\\:\\ 0\\.02403504740202199\ \(0\)\
\-\ current\\:\\ 0\\.023957064558246824\ \(0\)\
\-\ injuries\\:\\ 0\\.023842417523703054\ \(0\)\
\-\ though\\:\\ 0\\.023767481011239433\ \(0\)\
\-\ lucency\\:\\ 0\\.02354945077449415\ \(0\)\
\-\ radial\\:\\ 0\\.023478922456030782\ \(0\)\
\-\ sensation\\:\\ 0\\.023444043471584578\ \(0\)\
\-\ those\\:\\ 0\\.023409416323157153\ \(0\)\
\-\ mother\\:\\ 0\\.023375037400149543\ \(0\)\
\-\ american\\:\\ 0\\.023340903169058746\ \(0\)\
\-\ overlying\\:\\ 0\\.023307010171298274\ \(0\)\
\-\ incidentally\\:\\ 0\\.023307010171298274\ \(0\)\
\-\ ovarian\\:\\ 0\\.023307010171298274\ \(0\)\
\-\ lytic\\:\\ 0\\.02304415868099952\ \(0\)\
\-\ clinic\\:\\ 0\\.02304415868099952\ \(0\)\
\-\ displaced\\:\\ 0\\.02285606244652459\ \(0\)\
\-\ infarct\\:\\ 0\\.022764710365966303\ \(0\)\
\-\ their\\:\\ 0\\.022704761595093968\ \(0\)\
\-\ hernia\\:\\ 0\\.022645552951422843\ \(0\)\
\-\ 36\\:\\ 0\\.022645552951422843\ \(0\)\
\-\ review\\:\\ 0\\.022529284487968582\ \(0\)\
\-\ is\\:\\ 0\\.022475875035880936\ \(0\)\
\-\ femur\\:\\ 0\\.022443896370809322\ \(0\)\
\-\ via\\:\\ 0\\.02236000200019715\ \(0\)\
\-\ underlying\\:\\ 0\\.022332360199049647\ \(0\)\
\-\ near\\:\\ 0\\.0222775500113567\ \(0\)\
\-\ bones\\:\\ 0\\.02201251908942648\ \(0\)\
\-\ as\\:\\ 0\\.02198072588018729\ \(0\)\
\-\ general\\:\\ 0\\.021961226202384408\ \(0\)\
\-\ 35\\:\\ 0\\.021935784024823834\ \(0\)\
\-\ radiology\\:\\ 0\\.021910476107400233\ \(0\)\
\-\ 21\\:\\ 0\\.021860257436786094\ \(0\)\
\-\ limited\\:\\ 0\\.021835343930253177\ \(0\)\
\-\ osseous\\:\\ 0\\.021835343930253177\ \(0\)\
\-\ there\\:\\ 0\\.02177069942944956\ \(0\)\
\-\ done\\:\\ 0\\.021761370650479225\ \(0\)\
\-\ recommended\\:\\ 0\\.021761370650479225\ \(0\)\
\-\ arising\\:\\ 0\\.021736964291329267\ \(0\)\
\-\ not\\:\\ 0\\.021599953000585648\ \(0\)\
\-\ appear\\:\\ 0\\.021546059914358276\ \(0\)\
\-\ initially\\:\\ 0\\.02145338380879112\ \(0\)\
\-\ range\\:\\ 0\\.021229238379349265\ \(0\)\
\-\ motion\\:\\ 0\\.02120738941571607\ \(0\)\
\-\ repair\\:\\ 0\\.021163987859572474\ \(0\)\
\-\ cells\\:\\ 0\\.021078345597625125\ \(0\)\
\-\ symptomatic\\:\\ 0\\.02103609123422052\ \(0\)\
\-\ previous\\:\\ 0\\.020671675041178564\ \(0\)\
\-\ rare\\:\\ 0\\.020652219277284674\ \(0\)\
\-\ note\\:\\ 0\\.020594321118684547\ \(0\)\
\-\ malignancy\\:\\ 0\\.02048058047011176\ \(0\)\
\-\ second\\:\\ 0\\.02048058047011176\ \(0\)\
\-\ skin\\:\\ 0\\.020351205092739508\ \(0\)\
\-\ active\\:\\ 0\\.020314872803651334\ \(0\)\
\-\ radiographic\\:\\ 0\\.02029680935772991\ \(0\)\
\-\ confirmed\\:\\ 0\\.020172235101213642\ \(0\)\
\-\ tender\\:\\ 0\\.019999704293810774\ \(0\)\
\-\ calcifications\\:\\ 0\\.01996593063857989\ \(0\)\
\-\ breast\\:\\ 0\\.019866013707446267\ \(0\)\
\-\ since\\:\\ 0\\.019816825181658882\ \(0\)\
\-\ intact\\:\\ 0\\.019800540482743736\ \(0\)\
\-\ reported\\:\\ 0\\.01970397669925414\ \(0\)\
\-\ portion\\:\\ 0\\.01956268152711151\ \(0\)\
\-\ risk\\:\\ 0\\.01954723597681249\ \(0\)\
\-\ defined\\:\\ 0\\.01951649331242205\ \(0\)\
\-\ 24\\:\\ 0\\.019395456245412772\ \(0\)\
\-\ obtained\\:\\ 0\\.019350843465819754\ \(0\)\
\-\ palpable\\:\\ 0\\.019219442390752132\ \(0\)\
\-\ typically\\:\\ 0\\.0192050620524739\ \(0\)\
\-\ 50\\:\\ 0\\.0191055892285024\ \(0\)\
\-\ presentation\\:\\ 0\\.018832248064980607\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.01862426580661912\ \(0\)\
\-\ areas\\:\\ 0\\.01857364961938803\ \(0\)\
\-\ size\\:\\ 0\\.01852356207040512\ \(0\)\
\-\ 15\\:\\ 0\\.018486336740771925\ \(0\)\
\-\ palpation\\:\\ 0\\.018449398130259066\ \(0\)\
\-\ swelling\\:\\ 0\\.018412741855834584\ \(0\)\
\-\ joint\\:\\ 0\\.018026997621216356\ \(0\)\
\-\ finding\\:\\ 0\\.017982280847625036\ \(0\)\
\-\ several\\:\\ 0\\.017949014777441194\ \(0\)\
\-\ often\\:\\ 0\\.017850579045846384\ \(0\)\
\-\ injury\\:\\ 0\\.017839765424077787\ \(0\)\
\-\ between\\:\\ 0\\.017775390776684493\ \(0\)\
\-\ radiographs\\:\\ 0\\.017743524618098725\ \(0\)\
\-\ area\\:\\ 0\\.01772239753889867\ \(0\)\
\-\ known\\:\\ 0\\.017711868798725838\ \(0\)\
\-\ 20\\:\\ 0\\.017649177197225408\ \(0\)\
\-\ such\\:\\ 0\\.017597553025741345\ \(0\)\
\-\ examination\\:\\ 0\\.01750600718564432\ \(0\)\
\-\ image\\:\\ 0\\.01749594246165128\ \(0\)\
\-\ clinical\\:\\ 0\\.01733771485772414\ \(0\)\
\-\ usually\\:\\ 0\\.017222378496207388\ \(0\)\
\-\ some\\:\\ 0\\.017212891175165813\ \(0\)\
\-\ loss\\:\\ 0\\.016667016120508804\ \(0\)\
\-\ month\\:\\ 0\\.016641708203085206\ \(0\)\
\-\ changes\\:\\ 0\\.01653355806954754\ \(0\)\
\-\ on\\:\\ 0\\.01652469514870224\ \(0\)\
\-\ appearance\\:\\ 0\\.016492602746164202\ \(0\)\
\-\ through\\:\\ 0\\.016285096469410013\ \(0\)\
\-\ secondary\\:\\ 0\\.016215309380267447\ \(0\)\
\-\ if\\:\\ 0\\.015895219955257448\ \(0\)\
\-\ due\\:\\ 0\\.01572543800495458\ \(0\)\
\-\ therapy\\:\\ 0\\.01571849254505492\ \(0\)\
\-\ high\\:\\ 0\\.015548046773188932\ \(0\)\
\-\ common\\:\\ 0\\.015514672670359426\ \(0\)\
\-\ patients\\:\\ 0\\.015389927861762817\ \(0\)\
\-\ both\\:\\ 0\\.015255725069529194\ \(0\)\
\-\ abdominal\\:\\ 0\\.014962384881667005\ \(0\)\
\-\ noted\\:\\ 0\\.014504753694443082\ \(0\)\
\-\ man\\:\\ 0\\.014483247652922238\ \(0\)\
\-\ without\\:\\ 0\\.014429900726635756\ \(0\)\
\-\ imaging\\:\\ 0\\.014377140687129742\ \(0\)\
\-\ tissue\\:\\ 0\\.014350976742135806\ \(0\)\
\-\ most\\:\\ 0\\.014237521491018286\ \(0\)\
\-\ were\\:\\ 0\\.014101852246117591\ \(0\)\
\-\ it\\:\\ 0\\.014003774406295307\ \(0\)\
\-\ case\\:\\ 0\\.013743965776431633\ \(0\)\
\-\ surgical\\:\\ 0\\.013296497378632454\ \(0\)\
\-\ well\\:\\ 0\\.013246496864327523\ \(0\)\
\-\ lesion\\:\\ 0\\.013115655965778412\ \(0\)\
\-\ also\\:\\ 0\\.012868048441432682\ \(0\)\
\-\ by\\:\\ 0\\.01161745882193899\ \(0\)\
\-\ disease\\:\\ 0\\.011483585685295731\ \(0\)\
\-\ normal\\:\\ 0\\.011169766183221868\ \(0\)\
\-\ an\\:\\ 0\\.010461306001650615\ \(0\)\
\-\ history\\:\\ 0\\.010452038676597816\ \(0\)\
\-\ at\\:\\ 0\\.010333165269754316\ \(0\)\
\-\ patient\\:\\ 0\\.008897927669603579\ \(0\)\
